Drug
NOX-A12 clinical trials
Also written olaptesed pegol.
Keep track of what changes. Save the NOX-A12 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2012 (2)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 2 |
| 2017 | 1 |
| 2019 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 7 · Other 0
TME Pharma AG (7)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses NOX-A12 is read from its arms, and is right about nine times in ten.
Testing it · 7
- Olaptesed With Pembrolizumab and Nanoliposomal Irinotecan or Gemcitabine/Nab-Paclitaxel in MSS Pancreatic CancerNot yet recruitingPhase 2TME Pharma AGNCT04901741Written as Olaptesed pegol
- Glioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated PatientsActive, not recruitingPhase 1/2TME Pharma AGNCT04121455Written as Olaptesed pegol
- Olaptesed (NOX-A12) Alone and in Combination With Pembrolizumab in Colorectal and Pancreatic CancerCompletedPhase 1/2TME Pharma AGNCT03168139Written as Olaptesed pegol - Monotherapy
- NOX-A12 in Combination With Bendamustine and Rituximab in Relapsed Chronic Lymphocytic Leukemia (CLL)CompletedPhase 2TME Pharma AGNCT01486797Written as NOX-A12
- NOX-A12 in Combination With Bortezomib and Dexamethasone in Relapsed Multiple MyelomaCompletedPhase 2TME Pharma AGNCT01521533Written as NOX-A12
- NOX-A12 Multiple Ascending Dose Study in Healthy VolunteersCompletedPhase 1TME Pharma AGNCT01194934Written as NOX-A12
- NOX-A12 First-in-human (FIH) StudyCompletedPhase 1TME Pharma AGNCT00976378Written as NOX-A12
Codes
What other systems call NOX-A12 · ClinicalTrials.gg INT006478
- MeSH (NLM) C587878NOX-A12One source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C587878 | NOX-A12 | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.